Living With & Beyond Cancer
Women鈥檚 Health Initiative
The National Cancer Strategy 2017-2026 places emphasis on improving the quality of life and experience of people who have been diagnosed with cancer. In collaboration with investigators from the Enhancing Cancer Awareness & Survivorship Programmes (ECASP) group, we have developed a nurse-led pilot clinical trial to support women with a history of breast and gynaecological cancers in Cork 深夜亚洲福利久久 Hospital. This Irish Cancer Society supported 鈥淲omen鈥檚 Health Initiative鈥� is investigating the use of electronic patient reported outcomes (PROs), with the goal of improving symptom burden and quality of life for patients (Principal Investigators: Professor Roisin Connolly, Professor Josephine Hegarty).
LYSA Trial:
Living Beyond Lymphoma Cancer; Views and Experiences of Patients
This research study is being conducted as part of the Blood Cancer Network Ireland initiative, exploring the general experiences of patients with lymphoma during the survivorship phase with a focus on patient self-management during the pandemic (Principal Investigator: Professor Mary Cahill).
Men鈥檚 Heath Initiative
Advances in cancer treatment are greatly increasing survival rates for patients, however, the consequences of cancer and its treatment can result in significant, often lifelong, effects on health and quality of life. The National Cancer Strategy 2017-2026 places emphasis on improving the quality of life and experience of people who have been diagnosed with cancer. Similar to our Women's Health Initiative, and in collaboration with investigators from the ECASP group, we have developed a multidisciplinary interventional pilot clinical trial to provide men with genitourinary cancers (eg. prostate, kidney, bladder or testicular cancers) with the advice and support systems necessary to live beyond a metastatic cancer diagnosis. This Irish Cancer Society supported 鈥淢en鈥檚 Health Initiative鈥� is investigating a 12-week group based interventional programme, with particular emphasis on physiotherapy, dietetics, and psychosocial interventions, with the goal of improving symptom burden and quality of life for patients (Principal Investigators: Dr. Richard Bambury, Dr. Brendan Noonan).